Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

NCT05012631 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Diffuse Myocardial Fibrosis

Interventions

DRUG: Losartan

Sponsor

Children's Hospital Medical Center, Cincinnati